Loratadine 10 mg mouth dissolving tablet (MDT) was prepared by using super disintegrant such as sodium starch glycollate, crosscarmellose sodium, crospovidone at various concentration, aspartame was used as sweetening agent. The excipients were used for this study was based on the compatibillity studies. All the formulation was prepared by direct compression method. Among all the formulations crospovidone at 10 mg/tab gives 99.1% drug release at end of 12th min. It was considered as optimized batch. The optimized batch was processed for all the evaluation parameter and stability studies. The final formulations were packed in blister package.
Introduction
The main problem with the common oral dosage form is that they have to be swallowed along with water and many patients find it difficult to swallow tablet, especially in elderly and pediatrics, because of the physiological changes associated with them. Due to this dysphasic condition, they do not comply with prescription, which results in accent non compliance. Thus MDTs are beneficial to patients who find it difficult to swallow tablet, moreover some of the drugs which are soluble in saliva are absorbed from the mouth and pharynx and esophagus as the saliva passes down in to stomach, which enhances bioavailabilty by avoiding first pass metabolism. Loratadine is a long acting selective peripheral H1 antogonist that has been used as anti-cholinergic effect. The objective of the present study was to formulate and evaluate Loratadine by using super disintegrants to develop a new dosage form.
Materials and methods
Loratadine, sodium starch glycolate, croscarmellose sodium and crospovidone were obtained as a gift samples from Madras Pharmaceuticals, Chennai. All other reagents and solvent used were of analytical grade.
Methods

Direct Compression
The mouth dissolving tablets were prepared by direct compression method with the use of three different superdisintegrants namely Croscarmellose sodium, Sodium starch glycolate, Crospovidone in the ratio of 5:2, 5:3 and 5:4. Microcrystalline cellulose, Mannitol was used as a diluents and mixture of Aerosil and Magnesium sterate (1:1) was used as glidant and lubricant respectively. The composition of mouth dissolving loratadine is shown in Table I .
Accurate quantity of drug and all ingredients were weighed according to formula shown in Table I and powder except Aerosil and Magnesium sterate was blended homogeneously in mortor and pestle for 15 minutes. Prepared powder blend was passed through sieve no. #60. Finally Aerosil and Magnesium sterate passed from sieve no. #30 added and was further mixed for 10 minutes.
Accurately weighed 200 mg homogeneously mixed powder blend was fed manually and compressed with constant compression force and hardness on 16 stations Cadmach tablet compression machine with 9 mm, breakthrough, and flat faced punches. Total nine formulations were prepared.
Experimental Work Formulation and characterization of powder blend
Method
Accurate quantity of drug and all ingredients were weighed according to formula shown in Table I further mixed for 10 minutes. The powder blend was evaluated for angle of repose, bulk density, tapped density, Compressibility Index and Hausner ratio (Bankar et. al., 1996) .
Angle of Repose
Angle of repose was determined using cylinder method. The blend was poured through a funnel that can be raised vertically until a maximum cone height (h) was obtained. Radius of the heap (r) was measured and the angle of repose (θ) was calculated using the formula
Weighted quantity of loratadine was passed through funnel kept at height at 9 cm from base. The powder forms heap and touches the tip of the funnel. The radius was measured and angle of repose was calculated.
Standard Relationship between Angle of Repose (θ) and 
Bulk density
Apparent bulk density (ρ b ) was determined by pouring blend into a graduated cylinder. The bulk volume (V b ) and weight of the powder (M) was determined. The bulk density was calculated using the formula.
BD = Weight of the powder/Volume of the powder.
Tapped density
It was determined by placing a graduated cylinder, containing a known mass of drug excipients blend, which was tapped for a fixed time until the powder bed volume has reached a minimum. The minimum volume (V t ) occupied in the cylinder and the weight (m) of the blend was measured. The tapped density (ρ t ) was calculated using the following formula.
TBD = Weight of the powder/Tapped volume of the powder
Compressibility Index
The simplest way for measurement of free flow of powder is compressibility, a indication of the case with which a material can be induced to how is given by compressibility index (I) which is calculated as follows Very very poor For all the formulations bulk density, tupped density, angle of repose, Corr's index and Hansne's ratio are shown in Table II . The value below 15% indicates a powder will usually give rise to good flow characteristics, whereas above 25% indicate poor Flow ability.
Hausner's ratio
Hausner's ratio is an indirect index of ease of powder flow. It is calculated by the following formula;
Hausner's ratio= ρ t /ρ b
Where, ρ t is tapped density and ρ b is bulk density A hausner's ratio less than 1.25 indicates good flow while greater than 1.5 indicates poor flow.
Evaluation of loratidine MDTs Appearance
The tablets were visually observed for capping, chipping and lamination.
Weight variation
Twenty tablets were randomly selected from each batch and individually weighed. The average weight and standard deviation of 20 tablets were calculated. The batch passes the test for weight variation test if not more than two of the individual tablet weight deviate from the average weight. The results are shown in Table III .
Thickness uniformity
Three tablets were selected randomly from each batch and thickness was measured by using Vernier Caliper. The results are shown in Table III .
Hardness
Hardness or tablet crushing strength (Fo) the force required to break a tablet in a diametric compression was measured using Monsanto Hardness Tester. For each formulation, the hardness of 6 tablets was determined using the Monsanto hardness tester. The tablet was held along its oblong axis in between the two jaws of the tester. At this point, reading should be zero kg/cm 2 . Then constant force was applied by rotating the knob until the tablet fractured. The value at this point was noted in kg/cm 2 ( Bankar et. al., 1996) . The results are shown in Table III .
Friability
Friability of the tablets was determined using Roche Friabilator. This device subjects the tablets to the combined effect of abrasions and shock in a plastic chamber revolving at 25 rpm and roping the tablets ata height of 6 inches in each revolution. Preweighed sample of tablets was placed in the Friabilator and were subjected to 100 revolutions. Tablets were dedusted using a soft muslin cloth and reweighed, the friability (F) is given by the formula ( Bankar et. al., 1996) . The results are shown in Table III. % F = (Initial wt. -Final wt. / Initial wt.) x 100.
Content uniformity
The Loratadine content in the tablets was estimated as follows.
The tablet powder were weighed equivalent to 10 mg of Loratadine and dissolved in 100 mL of methanol and assayed for drug content using UV-Visible spectrophotometer at 275.00 nm (Anonymous, 2007) .
Disintegration time
The Disintegration time of the tablets was determined as per Indian Pharmacopoeia monograph. The test was carried out using USP Disintegrate Test apparatus, (Veego scientific VTD-DV). It consists of an apparatus in which 6 tablets was introduced into each of six cylindrical tubes, the lower end of which was covered by a 0.025 in wire mesh. The tubes were then raised and lowered through a distance of 5.3 to 5.7 cm in a test fluid phosphate buffer pH 6.8 and 0.1N HCl pH 1.2 as a disintegrating media maintained at 37 o ± 2 o C. and the time in second taken for complete disintegrate of the tablet with no palpable mass remaining in the apparatus was measured in seconds (Anonymous 2007; Chaudhari et. al., 2005) . The results are shown in Table IV .
Wetting time of water absorption Ratio
The wetting time characteristic of the loose disintegrant powder allows an evaluation of both the intrinsic swelling and the wettability of the super disintegrants. Wetting time of the ODT is important parameter, which needs to be assessed to give an insight into the disintegrate properties of the tablets; a lower wetting time implies a quicker disintegrate of the tablet. Wetting time was performed at room temperature (Chaudhari et. al., 2005; Gattani et. al., 2009) .
A piece of tissue paper of 10 cm folded twice was placed in small petri dish of diameter 10 cm containing 6 mL of water. A tablet was put on the paper and the time required for water to reach upper surface of tablet was noted. The results are shown in Table IV. For water absorption ratio the same wetted tablet was taken out from petri dish and weighed. Water absorption ratio (R) was determined by using following equation. 
In-vitro Dissolution studies
Dissolution profiles of Loratadine tablets were determined using the USP Type II Dissolution Test apparatus (Veego scientific VDA-8DR) set with a paddle speed of 100 rpm. Dissolution was performed in 900 mL of 0.1N HCl maintained at 370± 0.5 o C. Aliquot of dissolution medium, 5 mL was with drawn at 3, 6, 9, up to 12 min with 5 minutes interval, and filtered through Whatmann filter paper. The amount of drug dissolved was determined by UV-Visible spectrophotometer (Shimadzu-1700 Pharmaspec UV-VIS Spectrophotometer) by measuring the absorbance of the sample at 275 nm. An equal volume of fresh medium, prewarmed at 37 o C was replaced into the dissolution medium after each sampling to maintain the constant volume throughout the test. Three trials for each batch were performed and average percentage drug release was calculated by using PCP disso V3 software (Anonymous 2007; Gattani 2009; Lachman et. al., 1991) . The results are shown in Table V .
Uniformity of drug content
One tablet was crushed and transferred to a 50 mL volumetric flask, 20 mL of methanol was added, shaken well to dissolve the drug. The volume was made up to 100 mL with water and filtered. Then 5 mL of the filterate was diluted to 50 mL with water again from that 5 mL was taken and diluted to 50 mL with water. The results are shown in Table IV .
Stability study of tablets for formulation F9
Optimized formulation F9 sealed in blister packaging and various replicates were kept in the humidity chamber maintained at 40°C and 75 % RH for three months. At the end of the study the samples were analysed for the drug content and release studies and other physical parameter. The results of stability study after three month are given in The results are shown in Table VI .
Results and discussion
Pre-compression parameter (all formulation) of the drug excipients blend has been carried out such as Bulk density, Tapped density, Angle of repose and Carr's index. For F9 formulation the obtained value of Angle of repose (θ) was 26.59, Haussner's ratio 0.8968 and Carr's index 10.31 indicating good flow properties. All the parameters were falls within the limits. Then all the formulations have been evaluated for post-compression parameters. The thickness of all the tablets found in range of 2.8 --3.0 mm for all the formulations within the prescribed limits of IP 1996 (±5%). The tablet hardness was found to be 3-3.4 kg/cm 2 , the friability of all the formulations were found to be between 0.8 -0.9, which was found to be within the official requirement ( i.e. not more than 1% ). This value is indicator that the tablets were mechanically stable. The drug content estimation data for all the batches were found to be within the limits (i.e. 95.25 --99.50). Formulation F9 possess good disintegrating property among all the formulation which was observed during in-vitro disintegration, wetting time, in vitro dispersion time.
Formulation containing crospovidone F9 was showing better drug release at end of 12th mins (99.1%). All the formula tions were subjected to evaluation studies and from these formulation showed good matrix integrity and drug release rate. Overall results significance that crospovidone in the ratio 10 mg/tablet acts as good disintegrate for fast dissolving tablets. In-vitro dissolution results proved formulations F9 were better choice among all the formulations. Stability studies were conducted for all the formulation at 45 o C/75%
RH and 50 o C for a period of three months as per ICH guidelines.
During the study period several parameters like Hardness, In-vitro disintegration, Drug content uniformity and Wetting time were evaluated for possible instability problems. No significant changes in parameter were observed throughout the study period. In-vitro dissolution and Wetting time parameters signified that crospovidone in ratio 10 mg per tablet act as good disintegrates prepared by direct compression method. Overall combination F9 were found to be an excellent mouth dissolving tablets with good taste.
